litlas
Log inCreate account

D. James Surmeier

Active 1986–2025

187
Papers
45,177
Citations
116
h-index
186
i10-index

Citations

Citations per year for D. James Surmeier1951: 1 citations1952: 1 citations1966: 1 citations1983: 3 citations1986: 1 citations1987: 3 citations1988: 1 citations1989: 4 citations1990: 3 citations1991: 13 citations1992: 14 citations1993: 14 citations1994: 34 citations1995: 45 citations1996: 64 citations1997: 95 citations1998: 142 citations1999: 134 citations2000: 190 citations2001: 163 citations2002: 242 citations2003: 226 citations2004: 275 citations2005: 232 citations2006: 253 citations2007: 350 citations2008: 407 citations2009: 421 citations2010: 505 citations2011: 706 citations2012: 556 citations2013: 619 citations2014: 663 citations2015: 585 citations2016: 526 citations2017: 541 citations2018: 593 citations2019: 1,519 citations2020: 1,572 citations2021: 1,542 citations2022: 1,410 citations2023: 1,036 citations2024: 1,491 citations2025: 737 citations2026: 23 citations1953–1965: no citations, so these years are not shown1967–1982: no citations, so these years are not shown1984–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,930 citing papers, 35.2% of this breakdownChina: 1,323 citing papers, 7.9% of this breakdownUnited Kingdom: 1,120 citing papers, 6.6% of this breakdownGermany: 951 citing papers, 5.6% of this breakdownItaly: 758 citing papers, 4.5% of this breakdownFrance: 632 citing papers, 3.7% of this breakdownCanada: 622 citing papers, 3.7% of this breakdownJapan: 504 citing papers, 3% of this breakdownSpain: 430 citing papers, 2.6% of this breakdownSweden: 385 citing papers, 2.3% of this breakdownAustralia: 352 citing papers, 2.1% of this breakdownIndia: 300 citing papers, 1.8% of this breakdown
0%35.2%Other 21%

Institutions

Fields

  • Neuroscience36.6%
  • Medicine32.1%
  • Biochemistry, Genetics and Molecular Biology26.8%
  • Psychology1.2%
  • Engineering0.7%
  • Immunology and Microbiology0.5%
  • Other2.1%

Topics

  • Neuroscience and Neuropharmacology Research9.4%
  • Parkinson's Disease Mechanisms and Treatments7.5%
  • Neurological disorders and treatments4.8%
  • Neurotransmitter Receptor Influence on Behavior4.7%
  • Receptor Mechanisms and Signaling3.7%
  • Neural dynamics and brain function3.3%
  • Other66.6%

Coauthors

All papers

Open in search
  1. Negative feedback control of neuronal activity by microglia

    Authors: Ana Badimon, Hayley J. Strasburger, Pinar Ayata, Xinhong Chen, Aditya Nair, Ako Ikegami, Philip Hwang, Andrew Chan, Steven M. Graves, Joseph O. Uweru, Carola Ledderose, Munir Gunes Kutlu, Michael A. Wheeler, Anat Kahan, Masago Ishikawa, Ying‐Chih Wang, Yong‐Hwee Eddie Loh, Jean X. Jiang, D. James Surmeier, Simon C. Robson, Wolfgang G. Junger, Robert Sebra, Erin S. Calipari, Paul J. Kenny, Ukpong B. Eyo, Marco Colonna, Francisco J. Quintana, Hiroaki Wake, Viviana Gradinaru, Anne Schaefer - Nature 2020 cited by 1,023

  2. Disruption of mitochondrial complex I induces progressive parkinsonism

    Authors: Patricia González‐Rodríguez, Enrico Zampese, Kristen A. Stout, Jaime N. Guzmán, Ema Ilijić, Ben Yang, Tatiana Tkatch, Mihaela Stavarache, David L. Wokosin, Lin Gao, Michael G. Kaplitt, José López‐Barneo, Paul T. Schumacker, D. James Surmeier - Nature 2021 cited by 559

  3. Selective neuronal vulnerability in Parkinson disease

    Authors: D. James Surmeier, José Á. Obeso, Glenda M. Halliday - Nature reviews. Neuroscience 2017 cited by 1,128

  4. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease

    Authors: Sonja Kriks, Jaewon Shim, Jinghua Piao, Yosif Ganat, Dustin R. Wakeman, Zhong Xie, Luis Carrillo‐Reid, Gordon Auyeung, Christopher L. Antonacci, A. Buch, Lichuan Yang, M. Flint Beal, D. James Surmeier, Jeffrey H. Kordower, Viviane Tabar, Lorenz Studer - Nature 2011 cited by 1,957

  5. Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

    Authors: Martin T. Henrich, Wolfgang H. Oertel, D. James Surmeier, Fanni F. Geibl - Molecular Neurodegeneration 2023 cited by 380

  6. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

    Authors: Lena F. Burbulla, Pingping Song, Joseph R. Mazzulli, Enrico Zampese, Yvette C. Wong, Sohee Jeon, David P. Santos, Judith Blanz, Carolin D. Obermaier, Chelsee Strojny, Jeffrey N. Savas, Evangelos Kiskinis, Xiaoxi Zhuang, Rejko Krüger, D. James Surmeier, Dimitri Krainc - Science 2017 cited by 887

  7. Modulation of Striatal Projection Systems by Dopamine

    Authors: Charles R. Gerfen, D. James Surmeier - Annual Review of Neuroscience 2011 cited by 1,746

  8. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    Authors: José Á. Obeso, María Stamelou, Christopher G. Goetz, Werner Poewe, Anthony E. Lang, Daniel Weintraub, David J. Burn, Glenda M. Halliday, Erwan Bézard, Serge Przedborski, Stéphane Lehéricy, David J. Brooks, John C. Rothwell, Mark Hallett, Mahlon R. DeLong, Connie Marras, Caroline M. Tanner, G. Webster Ross, J. William Langston, Christine Klein, Vincenzo Bonifati, Joseph Jankovic, Andrés M. Lozano, Günther Deuschl, Hagai Bergman, Eduardo Tolosa, Mayela Rodríguez‐Violante, Stanley Fahn, Ronald B. Postuma, Daniela Berg, Kenneth Marek, David G. Standaert, D. James Surmeier, C. Warren Olanow, Jeffrey H. Kordower, Paolo Calabresi, Anthony H.V. Schapira, A. Jon Stoessl - Movement Disorders 2017 cited by 845

  9. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1

    Authors: Jaime N. Guzmán, Javier Sánchez-Padilla, David L. Wokosin, Jyothisri Kondapalli, Ema Ilijić, Paul T. Schumacker, D. James Surmeier - Nature 2010 cited by 851

  10. Determinants of dopaminergic neuron loss in Parkinson's disease

    Authors: D. James Surmeier - FEBS Journal 2018 cited by 461

  11. A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types

    Authors: Myriam Heiman, Anne Schaefer, Shiaoching Gong, Jayms D. Peterson, Michelle Day, Keri E. Ramsey, Mayte Suárez‐Fariñas, Cordelia S. Schwarz, Dietrich Stephan, D. James Surmeier, Paul Greengard, Nathaniel Heintz - Cell 2008 cited by 1,200

  12. Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity

    Authors: Weixing Shen, Marc Flajolet, Paul Greengard, D. James Surmeier - Science 2008 cited by 1,235

  13. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons

    Authors: D. James Surmeier, Jun Ding, Michelle Day, Zhongfeng Wang, Weixing Shen - Trends in Neurosciences 2007 cited by 1,186

  14. Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease

    Authors: Bryan Zeitler, Steven Froelich, Kimberly Marlen, David A. Shivak, Qi Yu, Davis Li, Jocelynn R. Pearl, Jeffrey C. Miller, Lei Zhang, David E. Paschon, Sarah J. Hinkley, Irina Ankoudinova, Stephen C.-T. Lam, Dmitry Guschin, Lexi Kopan, Jennifer M. Cherone, Hoang-Oanh B. Nguyen, Guijuan Qiao, Yasaman Ataei, Matthew Mendel, Rainier Amora, Richard Surosky, Josée Laganière, B. Joseph Vu, Anand Narayanan, Yalda Sedaghat, Karsten Tillack, Christina Thiede, Annette Gärtner, Seung Kwak, Jonathan Bard, Ladislav Mrzljak, Larry Park, Taneli Heikkinen, Kimmo Lehtimäki, Marie Svedberg, Jenny Häggkvist, Lenke Tari, Miklós Tóth, Andrea Varrone, Christer Halldin, Andrea E. Kudwa, Sylvie Ramboz, Michelle Day, Jyothisri Kondapalli, D. James Surmeier, Fyodor D. Urnov, Philip D. Gregory, Edward J. Rebar, Ignacio Muñoz-Sanjuán, H. Steve Zhang - Nature Medicine 2019 cited by 220

  15. ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease

    Authors: C. Savio Chan, Jaime N. Guzmán, Ema Ilijić, Jeff Mercer, Caroline Rick, Tatiana Tkatch, Gloria E. Meredith, D. James Surmeier - Nature 2007 cited by 916

  16. Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain

    Authors: Steven M. Graves, Zhong Xie, Kristen A. Stout, Enrico Zampese, Lena F. Burbulla, Jean C. Shih, Jyothisri Kondapalli, Tommaso Patriarchi, Lin Tian, Lars Brichta, Paul Greengard, Dimitri Krainc, Paul T. Schumacker, D. James Surmeier - Nature Neuroscience 2019 cited by 184

  17. Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations

    Authors: Tiago A. Mestre, Seyed-Mohammad Fereshtehnejad, Daniela Berg, Nicolaas I. Bohnen, Kathy Dujardin, Roberto Erro, Alberto J. Espay, Glenda Halliday, Jacobus J. van Hilten, Michele T. Hu, Beomseok Jeon, Christine Klein, Albert F.G. Leentjens, Johan Marinus, Brit Mollenhauer, Ronald Postuma, Rajasumi Rajalingam, Mayela Rodríguez-Violante, Tanya Simuni, D. James Surmeier, Daniel Weintraub, Michael P. McDermott, Michael Lawton, Connie Marras - Journal of Parkinson s Disease 2021 cited by 134

  18. Increased Lysosomal Exocytosis Induced by Lysosomal Ca2+ Channel Agonists Protects Human Dopaminergic Neurons from α-Synuclein Toxicity

    Authors: Taiji Tsunemi, Tamara Perez‐Rosello, Yuta Ishiguro, Asako Yoroisaka, Sohee Jeon, Kana Hamada, Malini Rammonhan, Yvette C. Wong, Zhong Xie, Wado Akamatsu, Joseph R. Mazzulli, D. James Surmeier, Nobutaka Hattori, Dimitri Krainc - Journal of Neuroscience 2019 cited by 162

  19. Determinants of seeding and spreading of α-synuclein pathology in the brain

    Authors: Martin T. Henrich, Fanni F. Geibl, Lakshminarasimhan Harini, Anna Stegmann, Benoit I. Giasson, Xiaobo Mao, Valina L. Dawson, Ted M. Dawson, Wolfgang H. Oertel, D. James Surmeier - Science Advances 2020 cited by 110

  20. Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons

    Authors: Enrico Zampese, David L. Wokosin, Patricia González‐Rodríguez, Jaime N. Guzmán, Tatiana Tkatch, Jyothisri Kondapalli, William C. Surmeier, Karis B. D’Alessandro, Diego De Stefani, Rosario Rizzuto, Masamitsu Iino, Jeffery D. Molkentin, Navdeep S. Chandel, Paul T. Schumacker, D. James Surmeier - Science Advances 2022 cited by 83

  21. Parkinson’s disease-linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons

    Authors: Pingping Song, Wesley Peng, Véronique Sauvé, Rayan Fakih, Zhong Xie, Daniel Ysselstein, Talia Krainc, Yvette C. Wong, Niccolò E. Mencacci, Jeffrey N. Savas, D. James Surmeier, Kalle Gehring, Dimitri Krainc - Neuron 2023 cited by 57

  22. M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

    Authors: Weixing Shen, Joshua L. Plotkin, Veronica Francardo, Wai Kin D. Ko, Zhong Xie, Qin Li, Tim Fieblinger, Jürgen Wess, Richard R. Neubig, Craig W. Lindsley, P. Jeffrey Conn, Paul Greengard, Erwan Bézard, M. Angela Cenci, D. James Surmeier - Neuron 2015 cited by 249

  23. Striatal synapses, circuits, and Parkinson's disease

    Authors: Shenyu Zhai, Asami Tanimura, Steven M. Graves, Weixing Shen, D. James Surmeier - Current Opinion in Neurobiology 2017 cited by 177

  24. Striatal synaptic adaptations in Parkinson's disease

    Authors: Weixing Shen, Shenyu Zhai, D. James Surmeier - Neurobiology of Disease 2022 cited by 74